Diagnostic Kits/Country Reports Review: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 5: | Line 5: | ||
Due to the length of the summaries and discussion, each country report has it's own page (linked below). This page will summarize the concerns identified and the conclusions reached by these country reports. | Due to the length of the summaries and discussion, each country report has it's own page (linked below). This page will summarize the concerns identified and the conclusions reached by these country reports. | ||
===[United States Country Report]=== | ==Reports by Country== | ||
===[Australia Country Report]=== | ===[[United_States_Country_Report (Diagnostic Kits)|United States Country Report]]=== | ||
===[Europe Country Report]=== | |||
===[[Australia Country Report]]=== | |||
===[[Europe Country Report]]=== | |||
==Navigation== | ==Navigation== | ||
Latest revision as of 11:36, 16 June 2010
A number of countries have solicited advisory reports on the state of governmental oversight and the affect of intellectual property issues concerning genetic testing. These reports were prepared independently in the United States, Europe, and Australia. Each report addressed issues specific to each countries’ intellectual property and regulatory schemes.
Due to the length of the summaries and discussion, each country report has it's own page (linked below). This page will summarize the concerns identified and the conclusions reached by these country reports.
Reports by Country
United States Country Report
Australia Country Report
Europe Country Report
Back to Main Page
Back to Diagnostic Kits